GW PHARMACEUTICALS PLC
DelistedCIK 1351288fmd_1M80ZYVSG4RDD099TXWS64FB16Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Oct 01, 2015 to Mar 31, 2021, 19 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| Total revenues | 13 | 9 | 13 | – | 527 |
| Cost of revenue | 4 | 5 | 6 | 27 | 38 |
| Gross profit | 9 | 4 | 7 | – | 490 |
| Research and development | 104 | 112 | 154 | 143 | 205 |
| Selling, general and administrative | 33 | 58 | 142 | 260 | 336 |
| Operating income | (129) | (166) | (289) | (118) | (52) |
| Interest expense | 0 | 1 | 1 | 1 | 1 |
| Interest and investment income | 1 | 2 | 4 | 8 | 2 |
| Income before taxes | (92) | (171) | (291) | (9) | (55) |
| Income tax expense | (1) | (1) | 4 | (0) | 3 |
| Net income from continuing operations | (92) | (170) | (295) | (9) | (58) |
| Net income | (92) | (170) | (295) | (9) | (58) |